GoAI
Get started
Beijing Health (Holdings) Limited logo

Beijing Health (Holdings) Limited

2389.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$0.081

−HK$0.001 · -1.22%

Aug 25, 3:52 PM HKT

2389.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial park and incubator projects; sports businesses, which includes construction and operation of stadiums for winter sports; and investment in the field of the biotechnology, pharmaceutical, medical services, and medical travel. The company also provides investment management consulting services; and engages in trading geriatric care related furniture. In addition, it is involved in medical and logistics related property development activities. The company was formerly known as Beijing Enterprises Medical and Health Industry Group Limited and changed its name to Beijing Health (Holdings) Limited in June 2021. Beijing Health (Holdings) Limited was founded in 1995 and is headquartered in Cheung Sha Wan, Hong Kong.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
HK
CEO
Xue Heng Liu
Listed since
Apr 26, 2002
Employees
207

Market position

52-week range

Current HK$0.081

Open
HK$0.081
Previous close
HK$0.082
Volume
0
0× average
Average volume
837.36K
Average daily volume
Market cap
490.76M HKD
Beta
-0.16
Market reference 1
50-day average
HK$0.0783
+3.50% above average
200-day average
HK$0.0699
+15.93% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-4.88×
P/B (TTM)
0.3×
P/S (TTM)
3.12×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
27.01%
Operating margin
-34.35%
Net margin
-64.19%

Financial health

Debt / equity
0.07×
Altman Z-score
0.02
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends38%-4%-46%-88%Gross margin, FY2021: 23.06%Gross margin, FY2022: 27.94%Gross margin, FY2023: 27.41%Gross margin, FY2024: 23.80%Gross margin, FY2025: 27.01%Operating margin, FY2021: -42.10%Operating margin, FY2022: -45.38%Operating margin, FY2023: -57.05%Operating margin, FY2024: -43.43%Operating margin, FY2025: -63.03%Net margin, FY2021: -19.34%Net margin, FY2022: -58.68%Net margin, FY2023: -44.09%Net margin, FY2024: -77.51%Net margin, FY2025: -64.19%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 23.06%. Gross margin FY2022 27.94%. Gross margin FY2023 27.41%. Gross margin FY2024 23.80%. Gross margin FY2025 27.01%. Operating margin FY2021 -42.10%. Operating margin FY2022 -45.38%. Operating margin FY2023 -57.05%. Operating margin FY2024 -43.43%. Operating margin FY2025 -63.03%. Net margin FY2021 -19.34%. Net margin FY2022 -58.68%. Net margin FY2023 -44.09%. Net margin FY2024 -77.51%. Net margin FY2025 -64.19%.

Income trends

Revenue

157.2M HKD+4.84%

Operating income

−99.09M HKD-52.16%

Net income

−100.91M HKD+13.17%
Income trends across reported periods235.78M HKD107.78M HKD−20.22M HKD−148.22M HKDRevenue, FY2021: 203.78M HKDRevenue, FY2022: 166.48M HKDRevenue, FY2023: 140.35M HKDRevenue, FY2024: 149.95M HKDRevenue, FY2025: 157.2M HKDOperating income, FY2021: −85.79M HKDOperating income, FY2022: −75.55M HKDOperating income, FY2023: −80.07M HKDOperating income, FY2024: −65.12M HKDOperating income, FY2025: −99.09M HKDNet income, FY2021: −39.41M HKDNet income, FY2022: −97.7M HKDNet income, FY2023: −61.88M HKDNet income, FY2024: −116.22M HKDNet income, FY2025: −100.91M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 203.78M HKD. Revenue FY2022 166.48M HKD. Revenue FY2023 140.35M HKD. Revenue FY2024 149.95M HKD. Revenue FY2025 157.2M HKD. Operating income FY2021 −85.79M HKD. Operating income FY2022 −75.55M HKD. Operating income FY2023 −80.07M HKD. Operating income FY2024 −65.12M HKD. Operating income FY2025 −99.09M HKD. Net income FY2021 −39.41M HKD. Net income FY2022 −97.7M HKD. Net income FY2023 −61.88M HKD. Net income FY2024 −116.22M HKD. Net income FY2025 −100.91M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue157.2M HKD149.95M HKD140.35M HKD166.48M HKD203.78M HKD
Cost of goods sold114.75M HKD114.27M HKD101.87M HKD119.97M HKD156.79M HKD
Gross profit42.45M HKD35.68M HKD38.47M HKD46.51M HKD46.99M HKD
Selling, general, and administrative95.15M HKD34.57M HKD38.76M HKD111.96M HKD132.88M HKD
Operating expenses96.45M HKD95.47M HKD104.38M HKD115.7M HKD132.78M HKD
Interest income19.05M HKD4.85M HKD15.61M HKD14.43M HKD20.48M HKD
Interest expense2.52M HKD228K HKD376K HKD1.44M HKD2.07M HKD
Depreciation and amortization21.68M HKD21.72M HKD24.21M HKD26.01M HKD34.18M HKD
Operating income−99.09M HKD−65.12M HKD−80.07M HKD−75.55M HKD−85.79M HKD
Net income−100.91M HKD−116.22M HKD−61.88M HKD−97.7M HKD−39.41M HKD

Company facts updated Aug 25, 2026.

Earnings

Latest fiscal-year EPS
-0.017
FY2025
Latest fiscal-year revenue
157.2M HKD
FY2025 · +4.84% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend-0.01-0.01-0.02-0.02FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend210.12M184.75M159.38M134MFY21FY22FY23FY24FY25

2389.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$204.2

+3.29%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.50

+0.09%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$223.2

+0.81%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$52.20

+7.41%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.58

+1.67%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$100.1

+0.60%

Continue in GoAI

Research 2389.HK

research.disclaimer